Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose effects on postoperative delirium after major surgery in elderly patients
ChiCTR-IPD-17010950Phase 4Completed
- Sponsor
- Department of Anesthesiology, Cancer Hospital of Harbin Medical University
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in post-operative cognitive decline (POCD), postoperative delirium (POD) and postoperative pain (4 arms), sponsored by Department of Anesthesiology, Cancer Hospital of Harbin Medical University. Primary endpoints: Pain scores by VAS, Delirium and 1 more. Started Apr 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
post-operative cognitive decline (POCD)postoperative delirium (POD)postoperative pain
Beyond the preview
Go deeper on ChiCTR-IPD-17010950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPD-17010950.